ClinicalTrials.gg
Not yet recruitingNCT07941752DENT-STRESSUpdated Nov 17, 2026

Dental Anxiety and Stress Response During Dental Treatment in Children

An observational study in Dental Anxiety in Children, sponsored by Universidad de Murcia. Not yet recruiting. Open to participants aged 6 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Universidad de Murcia · Observational

How we know

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
120
Ages
6 Years to 10 Years
Sex
All
01

Study summary

Dental anxiety is common in children and can affect their behavior and cooperation during dental treatment. However, it is not fully understood how children's dental anxiety is related to their body's biological stress response.

The aim of this observational study is to investigate the relationship between dental anxiety, salivary stress biomarkers, and children's behavior during restorative dental treatment.

Children aged 6 to 10 years who require restorative dental treatment with local anesthesia will be invited to participate. Dental fear will be assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS), and anxiety at different stages of the appointment will be assessed using a facial rating scale. Children's behavior during treatment will be evaluated using the Frankl Behavior Rating Scale.

Three saliva samples will be collected: before treatment, immediately after treatment, and approximately 20-30 minutes after treatment. These samples will be used to measure cortisol and alpha-amylase, two biological markers associated with the stress response.

The study will examine whether children with higher levels of dental anxiety show different biological stress responses or behavioral patterns during dental treatment. The findings may help improve the assessment and management of dental anxiety in pediatric dental care.

All dental treatments will be provided according to routine clinical needs. Participation in the study will not determine the type of dental treatment received.

Read the detailed description

This is a prospective, observational, analytical study with repeated measurements designed to investigate the association between dental anxiety, behavioral responses, and salivary biomarkers of stress in children undergoing restorative dental treatment under local anesthesia.

The study will include children aged 6-10 years who require restorative dental treatment involving local anesthesia and who have not previously undergone this type of treatment. Written informed consent will be obtained from parents or legal guardians, together with age-appropriate assent from the children.

Dental fear will be assessed before treatment using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS). Situational anxiety will be evaluated using a facial rating scale at different stages of the dental appointment. Children's behavior during treatment will be assessed using the Frankl Behavior Rating Scale.

Saliva samples will be collected at three time points:

  • T0: Approximately 20-30 minutes before dental treatment.
  • T1: Immediately after completion of dental treatment.
  • T2: Approximately 20-30 minutes after completion of dental treatment.

Salivary cortisol and alpha-amylase will be measured to assess biological stress responses. Changes in biomarker concentrations across sampling points will be examined in relation to dental fear, situational anxiety, and observed behavior.

The study is planned to involve dental centers in Valencia and Barcelona, Spain. Due to organizational constraints, saliva collection will take place in the morning at the Valencia center and in the afternoon at the Barcelona center. Because salivary cortisol and alpha-amylase show diurnal variation, the exact sampling times and participants' awakening times will be recorded. The analyses will consider within-participant biomarker changes and potential differences between centers. Since center and sampling period are associated by design, their independent effects cannot be fully distinguished.

No experimental dental treatment will be assigned. All participants will receive clinically indicated restorative dental care, and the research procedures will consist of questionnaires, behavioral observation, and non-invasive saliva collection.

02

Conditions studied

  • Dental Anxiety in Children

Keywords

  • pediatric dentistry
  • salivary cortisol
  • dental fear
  • stress response
03

In context

Lead sponsor

Universidad de Murcia is the lead sponsor of 81 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population will consist of children aged 6 to 10 years attending the University Dental Clinics of the University of Barcelona and the University of Valencia (Spain) who require restorative dental treatment under local anesthesia.

Eligible children will be recruited during routine pediatric dental appointments. All participants will receive standard dental care, and dental fear, situational anxiety, clinical behavior, and salivary stress biomarkers will be assessed during a single dental visit.

The study will be coordinated by the University of Murcia, which will be responsible for salivary biomarker analysis and data analysis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children aged 6 to 10 years.
  • Children requiring restorative dental treatment under local anesthesia.
  • Ability to understand and respond to the study assessment scales.
  • Written from a parent or legal guardian and assent from the child.

Exclusion criteria

Exclusion Criteria:

  • Systemic or endocrine diseases.
  • Use of medications that may alter the physiological stress response, including , anxiolytics, or similar medications.
  • Acute infection, fever, or severe pain before dental treatment.
  • Salivary disorders or active oral bleeding.
  • Failure to comply with the instructions provided before saliva collection.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
120 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Children Undergoing Restorative Dental Treatment

    Children aged 6-10 years undergoing their first restorative dental treatment requiring local anesthesia will be included in this observational cohort. Dental fear will be assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS), situational anxiety using a facial rating scale, and behavior during treatment using the Frankl Behavior Rating Scale. Three saliva samples will be collected: approximately 20-30 minutes before treatment (T0), immediately after treatment (T1), and 20-30 minutes after treatment (T2). Salivary cortisol and alpha-amylase will be analyzed as biomarkers of the stress response. All participants will receive routine, clinically indicated dental treatment. No experimental treatment will be assigned.

    Diagnostic Test: 1. Salivary Cortisol and Alpha-Amylase Measurement

Interventions

  • Diagnostic test1. Salivary Cortisol and Alpha-Amylase Measurement

    1. Three saliva samples will be collected from each participant: 20-30 minutes before dental treatment (T0), immediately after treatment (T1), and 20-30 minutes after treatment (T2). Salivary cortisol and alpha-amylase concentrations will be measured to evaluate physiological stress responses. 2. Dental fear will be assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS) during the pre-treatment assessment. Situational anxiety will be measured using the Facial Image Scale (FIS) immediately before dental treatment, immediately after treatment, and 20-30 minutes after treatment. 3. Children's behavior during restorative dental treatment will be assessed by a clinical evaluator using the four-category Frankl Behavior Rating Scale. Behavioral observations, including crying, refusal of anesthesia, and treatment interruptions, will also be recorded.

    Also known as: 2. Dental Fear and Anxiety Assessment, 3. Behavioral Assessment Using the Frankl Scale

06

What researchers measure

Primary outcomes

  1. Change in Salivary Cortisol Concentration

    Salivary cortisol concentration will be measured at three time points to assess the physiological stress response to dental treatment. Changes from baseline (T0) to immediately after treatment (T1) and 20-30 minutes after treatment (T2) will be evaluated. Concentrations will be reported in nmol/L.

    Time frame: Day 1: T0 (20-30 minutes before treatment), T1 (immediately after treatment), and T2 (20-30 minutes after treatment)

  2. Change in Salivary Alpha-Amylase Activity

    Salivary alpha-amylase activity will be measured at three time points to assess the physiological stress response to dental treatment. Changes from baseline (T0) to immediately after treatment (T1) and 20-30 minutes after treatment (T2) will be evaluated. Activity will be reported in U/mL.

    Time frame: Day 1: T0 (20-30 minutes before treatment), T1 (immediately after treatment), and T2 (20-30 minutes after treatment)

Secondary outcomes

  1. Dental Fear Score Assessed by the CFSS-DS

    Dental fear will be assessed using the Children's Fear Survey Schedule-Dental Subscale (CFSS-DS), consisting of 15 items scored from 1 to 5. Total scores range from 15 to 75, with higher scores indicating greater dental fear.

    Time frame: Baseline (Day 1), before dental treatment.

  2. Situational Dental Anxiety Assessed by the Facial Image Scale

    Situational dental anxiety will be assessed using the Facial Image Scale (FIS), a five-point pictorial scale ranging from 1 (very happy) to 5 (very unhappy). Higher scores indicate greater anxiety. Scores will be recorded at three time points to evaluate changes during the dental appointment.

    Time frame: Day 1: before treatment (T0), immediately after treatment (T1), and 20-30 minutes after treatment (T2)

  3. Child Behavior Assessed by the Frankl Behavior Rating Scale

    Children's behavior during restorative dental treatment will be evaluated using the Frankl Behavior Rating Scale, which classifies behavior into four categories: 1 (definitely negative), 2 (negative), 3 (positive), and 4 (definitely positive). Higher scores indicate more cooperative behavior.

    Time frame: Day 1, during dental treatment (periprocedural)

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be publicly shared because the study involves children and collects sensitive health-related and behavioral information. Data will be securely stored and accessed only by authorized members of the research team, in accordance with applicable data protection regulations and the approved study protocol. Study findings will be published in aggregated form, without identifying individual participants.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for Feb 2027, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 5, 2026
First posted
Nov 17, 2026
StartEst.
Jan 11, 2027
Primary completionEst.
Feb 11, 2027
CompletionEst.
Jun 2027
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941752
Lead sponsor
Universidad de Murcia
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Jan 11, 2027 (estimated)
Primary completion
Feb 11, 2027 (estimated)
Completion
Jun 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Olga Cortes Lillo, DDS,PhD
Contact
ocortes@um.es
+34868888585

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion